Deutsch English Français

Contact

EP2928303

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP2928303

EP2928303 - FACTOR VIII MUTATION REPAIR AND TOLERANCE INDUCTION [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 27.10.2023 Database last updated on 28.09.2024
Former	Examination is in progress Status updated on 08.09.2017
Former	Request for examination was made Status updated on 13.02.2017
Most recent event Tooltip	27.10.2023	Application deemed to be withdrawn	published on 29.11.2023 [2023/48]
Applicant(s)	For all designated states Haplomics, Inc. 458 Edgewood Ave. Atlanta, GA 30303 / US
	For all designated states The Regents of the University of California 1111 Franklin Street, 12th Floor Oakland, CA 94607 / US
	For all designated states The Government of the United States of America, as represented by The Department of Veterans Affairs 810 Vermont Avenue, NW Washington, DC 20420 / US
	[2015/42]
Inventor(s)	01 / LATERZA, Vincent 526 Durand Drive Atlanta, GA 30307 / US
	02 / HOWARD, Tommy, E. 2703 Ruhland Ave. Apt. 3 Redondo Beach, CA 90278 / US
	[2015/42]
Representative(s)	Murgitroyd & Company 165-169 Scotland Street Glasgow G5 8PL / GB
	[N/P]
Former [2015/42]	Thom, Russell Murgitroyd & Company Scotland House 165-169 Scotland Street Glasgow G5 8PL / GB
Application number, filing date	13860153.9	06.12.2013
	[2015/42]
	WO2013US73751
Priority number, date	US201261734678P	07.12.2012 Original published format: US 201261734678 P
	US201361888424P	08.10.2013 Original published format: US 201361888424 P
	[2015/42]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO2014089541
	Date:	12.06.2014
	Language:	EN
	[2014/24]
	Type:	A2 Application without search report
	No.:	EP2928303
	Date:	14.10.2015
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 12.06.2014 takes the place of the publication of the European patent application.
	[2015/42]
Search report(s)	International search report - published on:	US	29.01.2015
	(Supplementary) European search report - dispatched on:	EP	13.06.2016
Classification	IPC:	A01N63/00, C12N5/00, C12N1/00, C12N5/071	[2015/42]
	CPC:	C07K14/755 (EP,US); A61K48/0066 (US); C12N15/90 (EP,US); C12N9/22 (EP,US); A61K38/00 (EP,US); C12N2830/42 (EP,US)
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2015/42]
Title	German:	FAKTOR-VIII-MUTATIONSREPARATUR UND TOLERANZINDUKTION	[2015/42]
	English:	FACTOR VIII MUTATION REPAIR AND TOLERANCE INDUCTION	[2015/42]
	French:	RÉPARATION DE LA MUTATION DU FACTEUR VIII ET INDUCTION DE LA TOLÉRANCE	[2015/42]
Entry into regional phase	05.06.2015	National basic fee paid
	05.06.2015	Search fee paid
	05.06.2015	Designation fee(s) paid
	05.06.2015	Examination fee paid
Examination procedure	05.06.2015	Examination requested [2015/42]
	21.04.2017	Amendment by applicant (claims and/or description)
	06.09.2017	Despatch of a communication from the examining division (Time limit: M06)
	21.06.2018	Reply to a communication from the examining division
	23.08.2018	Despatch of a communication from the examining division (Time limit: M06)
	07.06.2019	Reply to a communication from the examining division
	20.10.2020	Despatch of a communication from the examining division (Time limit: M04)
	26.02.2021	Reply to a communication from the examining division
	01.07.2021	Despatch of a communication from the examining division (Time limit: M06)
	28.12.2021	Reply to a communication from the examining division
	01.07.2023	Application deemed to be withdrawn, date of legal effect [2023/48]
	21.07.2023	Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2023/48]
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 06.09.2017
Request for further processing for:	The application is deemed to be withdrawn due to failure to reply to the examination report
	07.06.2019	Request for further processing filed
	07.06.2019	Full payment received (date of receipt of payment) Request granted
	21.06.2019	Decision despatched
	The application is deemed to be withdrawn due to failure to reply to the examination report
	21.06.2018	Request for further processing filed
	21.06.2018	Full payment received (date of receipt of payment) Request granted
	05.07.2018	Decision despatched
	The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
	21.04.2017	Request for further processing filed
	21.04.2017	Full payment received (date of receipt of payment) Request granted
	03.05.2017	Decision despatched
Fees paid	Renewal fee
	28.12.2015	Renewal fee patent year 03
	27.12.2016	Renewal fee patent year 04
	07.06.2018	Renewal fee patent year 05
	30.05.2019	Renewal fee patent year 06
	27.05.2020	Renewal fee patent year 07
	31.12.2020	Renewal fee patent year 08
	30.12.2021	Renewal fee patent year 09
	Penalty fee
	Additional fee for renewal fee
	31.12.2017	05 M06 Fee paid on 07.06.2018
	31.12.2018	06 M06 Fee paid on 30.05.2019
	31.12.2019	07 M06 Fee paid on 27.05.2020
	31.12.2022	10 M06 Not yet paid
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[Y]WO2004037977 (CALIFORNIA INST OF THECHNOLOGY [US], et al) [Y] 1-15* the whole document *;
		[Y]WO2012051343 (PHILADELPHIA CHILDREN HOSPITAL [US], et al) [Y] 1-15 * [0004], [0005], [0008]-[0009], [0032], [0094], [0012], [0123], [0100],[0017], [0018], [0031], [0013], [0027], [0063], [0129], [0153], [0050], [0147]-[0148] The description has an error in the numbering [0100]* is between [0125] and [0126].;; examples 1 ,3, 5; claim 5 *;
		[E]WO2014186585 (SANGAMO BIOSCIENCES INC [US]) [E] 1-7,10,12,13 * [0009]-[0010], [0020]-[0022], [0028]-[0029], [0041], [0063], [0175], [0183], [0199];; claims 1-3, 6-7, 10-11, 13 *;
		[Y] - H. J. LEE ET AL, "Targeted chromosomal duplications and inversions in the human genome using zinc finger nucleases", GENOME RESEARCH, (20111219), vol. 22, no. 3, doi:10.1101/gr.129635.111, ISSN 1088-9051, pages 539 - 548, XP055243750 [Y] 1-15 * p. 1 col. 2 li. 28-30, p. 6 col. 1 li. 22-p. 6 col. 2 li. 2, p. 1 col. 2 li. 28-34, p. 7 col. 2 li. 33-50 * * abstract * DOI: http://dx.doi.org/10.1101/gr.129635.111
		[Y] - R. D. BAGNALL ET AL, "Recurrent inversion breaking intron 1 of the factor VIII gene is a frequent cause of severe hemophilia A", BLOOD, US, (20020101), vol. 99, no. 1, doi:10.1182/blood.V99.1.168, ISSN 0006-4971, pages 168 - 174, XP055277058 [Y] 1-15 * the whole document * DOI: http://dx.doi.org/10.1182/blood.V99.1.168
		[Y] - NING SUN ET AL, "Recent advances in targeted genome engineering in mammalian systems", BIOTECHNOLOGY JOURNAL, (20120910), vol. 7, no. 9, doi:10.1002/biot.201200038, ISSN 1860-6768, pages 1074 - 1087, XP055187010 [Y] 1-15 * the whole document * DOI: http://dx.doi.org/10.1002/biot.201200038
		[Y] - J. ZOU ET AL, "Oxidase-deficient neutrophils from X-linked chronic granulomatous disease iPS cells: functional correction by zinc finger nuclease-mediated safe harbor targeting", BLOOD, (20110526), vol. 117, no. 21, doi:10.1182/blood-2010-12-328161, ISSN 0006-4971, pages 5561 - 5572, XP055040721 [Y] 1-15 * the whole document * DOI: http://dx.doi.org/10.1182/blood-2010-12-328161
	International search	[Y]WO2012051343 (PHILADELPHIA CHILDREN HOSPITAL [US], et al);
	by applicant	US4186183
		US4217344
		US4235871
		US4261975
		US4485054
		US4501728
		US4774085
		US4797368
		US4837028
		US4897355
		US4946787
		US5049386
		WO9116024
		WO9117424
		US5173414
		WO9324641
		US6008336
		US6453242
		US6503717
		US6534261
		US6599692
		US6607882
		US6689558
		WO2004037977
		US6824978
		US6933113
		US6979539
		US7013219
		WO2006063031
		US7163824
		US2009054985
		WO2012051343
		WO2014186585
		US19470618025
		WO1994US05700

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p